OLECLUMAB: 118 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
118
Total FAERS Reports
14 (11.9%)
Deaths Reported
102
Hospitalizations
118
As Primary/Secondary Suspect
12
Life-Threatening
First Report: 20170311 · Latest Report: 20231103
What Are the Most Common OLECLUMAB Side Effects?
#1 Most Reported
Acute kidney injury
10 reports (8.5%)
#2 Most Reported
Small intestinal obstruction
7 reports (5.9%)
#3 Most Reported
Pyrexia
6 reports (5.1%)
All OLECLUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 10 | 8.5% | 0 | 9 |
| Small intestinal obstruction | 7 | 5.9% | 1 | 7 |
| Drug-induced liver injury | 6 | 5.1% | 1 | 1 |
| Pyrexia | 6 | 5.1% | 1 | 6 |
| Drug ineffective | 5 | 4.2% | 0 | 0 |
| Pneumonia | 5 | 4.2% | 2 | 5 |
| Pneumonitis | 5 | 4.2% | 0 | 5 |
Who Reports OLECLUMAB Side Effects? Age & Gender Data
Gender: 41.7% female, 58.3% male. Average age: 63.4 years. Most reports from: US. View detailed demographics →
Is OLECLUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 4 | 1 | 4 |
| 2018 | 12 | 4 | 11 |
| 2019 | 69 | 8 | 67 |
| 2020 | 10 | 0 | 9 |
| 2021 | 1 | 0 | 1 |
| 2023 | 11 | 1 | 10 |
What Is OLECLUMAB Used For?
| Indication | Reports |
|---|---|
| Pancreatic carcinoma metastatic | 48 |
| Ductal adenocarcinoma of pancreas | 31 |
| Adenocarcinoma pancreas | 10 |
| Non-small cell lung cancer | 10 |
| Pancreatic carcinoma | 7 |
OLECLUMAB vs Alternatives: Which Is Safer?
OLECLUMAB vs OLIVE OIL\SOYBEAN OIL
OLECLUMAB vs OLMESARTAN
OLECLUMAB vs OLMESARTAN MEDOXOMIL
OLECLUMAB vs OLMETEC
OLECLUMAB vs OLODATEROL
OLECLUMAB vs OLODATEROL\TIOTROPIUM
OLECLUMAB vs OLOPATADINE
OLECLUMAB vs OLUTASIDENIB
OLECLUMAB vs OMACETAXINE MEPESUCCINATE
OLECLUMAB vs OMADACYCLINE
Official FDA Label for OLECLUMAB
Official prescribing information from the FDA-approved drug label.